Terms: = Breast cancer AND RECQL4, RecQ4, 9401, ENSG00000160957, RECQ4, RTS AND Treatment
30 results:
1. A Novel Germline Pathogenic Variant of
Amin M; Mahmoodi-Khaledi E; Narrei S; Zeinalian M
Iran J Med Sci; 2023 Jul; 48(4):420-424. PubMed ID: 37456212
[TBL] [Abstract] [Full Text] [Related]
2. Hrq1/recql4 regulation is critical for preventing aberrant recombination during DNA intrastrand crosslink repair and is upregulated in breast cancer.
Luong TT; Li Z; Priedigkeit N; Parker PS; Böhm S; Rapchak K; Lee AV; Bernstein KA
PLoS Genet; 2022 Sep; 18(9):e1010122. PubMed ID: 36126066
[TBL] [Abstract] [Full Text] [Related]
3. Can Radiologic Tumor Size Following Neoadjuvant Therapy Reliably Guide Tissue Resection in breast Conserving Surgery in Patients with Invasive breast cancer?
Walcott-Sapp S; Srour MK; Lee M; Luu M; Amersi F; Giuliano A; Chung A
Am Surg; 2020 Oct; 86(10):1248-1253. PubMed ID: 33284669
[TBL] [Abstract] [Full Text] [Related]
4. Werner Syndrome Protein Expression in breast cancer.
Savva C; Sadiq M; Sheikh O; Karim S; Trivedi S; Green AR; Rakha EA; Madhusudan S; Arora A
Clin Breast Cancer; 2021 Feb; 21(1):57-73.e7. PubMed ID: 32919863
[TBL] [Abstract] [Full Text] [Related]
5. Supporting and preparing patients for radiotherapy: Patients' and radiation therapists' perspectives on their one-to-one consultations.
Halkett GKB; Merchant S; Smith SK; O'Connor M; Jefford M; Aranda S; Schofield P
Eur J Cancer Care (Engl); 2020 Nov; 29(6):e13284. PubMed ID: 32656882
[TBL] [Abstract] [Full Text] [Related]
6. Next-generation sequencing identifies recurrent copy number variations in invasive breast carcinomas from Ghana.
Anwar T; Rufail ML; Djomehri SI; Gonzalez ME; Lazo de la Vega L; Tomlins SA; Newman LA; Kleer CG
Mod Pathol; 2020 Aug; 33(8):1537-1545. PubMed ID: 32152520
[TBL] [Abstract] [Full Text] [Related]
7. Comparing breast Conservation Surgery Seromas Contoured by Radiation Therapists versus those Contoured by a Radiation Oncologist in Radiation Therapy Planning for Early-Stage breast cancer.
Oultram S; Dempsey S; Greer P; Clapham M
J Med Imaging Radiat Sci; 2020 Mar; 51(1):108-116. PubMed ID: 31983574
[TBL] [Abstract] [Full Text] [Related]
8. Changes in taste and food preferences in breast cancer patients receiving chemotherapy: a pilot study.
Kim YH; Kim GM; Son S; Song M; Park S; Chung HC; Lee SM
Support Care Cancer; 2020 Mar; 28(3):1265-1275. PubMed ID: 31230121
[TBL] [Abstract] [Full Text] [Related]
9. Elevated Risk of Radiation Therapy-Associated Second Malignant Neoplasms in Young African-American Women Survivors of Stage I-IIIA breast cancer.
Xie L; Bao X; Cai T; Silva SG; Ma J; Zhang Z; Guo X; Marks LB
Int J Radiat Oncol Biol Phys; 2019 Oct; 105(2):275-284. PubMed ID: 31201893
[TBL] [Abstract] [Full Text] [Related]
10. Patterns of Practice in Canadian Radiation treatment Centres: Results of a National Survey.
Giddings A; Nica L; French J; Davis CA; Smoke M; Bolderston A
J Med Imaging Radiat Sci; 2018 Mar; 49(1):23-30. PubMed ID: 30479283
[TBL] [Abstract] [Full Text] [Related]
11. Camptothecin targets WRN protein: mechanism and relevance in clinical breast cancer.
Shamanna RA; Lu H; Croteau DL; Arora A; Agarwal D; Ball G; Aleskandarany MA; Ellis IO; Pommier Y; Madhusudan S; Bohr VA
Oncotarget; 2016 Mar; 7(12):13269-84. PubMed ID: 26959889
[TBL] [Abstract] [Full Text] [Related]
12. Investigation of variability in image acquisition and contouring during 3D ultrasound guidance for partial breast irradiation.
Landry A; Berrang T; Gagne I; Popescu C; Mitchell T; Vey H; Sand L; Soh SY; Wark J; Olivotto I; Beckham W
Radiat Oncol; 2014 Jan; 9():35. PubMed ID: 24467876
[TBL] [Abstract] [Full Text] [Related]
13. DNA repair gene patterns as prognostic and predictive factors in molecular breast cancer subtypes.
Santarpia L; Iwamoto T; Di Leo A; Hayashi N; Bottai G; Stampfer M; André F; Turner NC; Symmans WF; Hortobágyi GN; Pusztai L; Bianchini G
Oncologist; 2013; 18(10):1063-73. PubMed ID: 24072219
[TBL] [Abstract] [Full Text] [Related]
14. Six-year analysis of treatment-related toxicities in patients treated with accelerated partial breast irradiation on the American Society of breast Surgeons MammoSite breast Brachytherapy registry trial.
Khan AJ; Arthur D; Vicini F; Beitsch P; Kuerer H; Goyal S; Lyden M; Haffty BG
Ann Surg Oncol; 2012 May; 19(5):1477-83. PubMed ID: 22109731
[TBL] [Abstract] [Full Text] [Related]
15. Tailored chemotherapy doses based on toxicity in breast cancer result in similar quality of life values, irrespective of given dose levels.
Iiristo M; Wiklund T; Wilking N; Bergh J; Brandberg Y
Acta Oncol; 2011 Apr; 50(3):338-43. PubMed ID: 21323491
[TBL] [Abstract] [Full Text] [Related]
16. Electron arc therapy for bilateral chest wall irradiation: treatment planning and dosimetric study.
Sharma PK; Jamema SV; Kaushik K; Budrukkar A; Jalali R; Deshpande DD; Tambe CM; Sarin R; Munshi A
Clin Oncol (R Coll Radiol); 2011 Apr; 23(3):216-22. PubMed ID: 21185700
[TBL] [Abstract] [Full Text] [Related]
17. Dosimetric parameters in partial breast irradiation through brachytherapy.
Gloi A; McCourt S; Buchanan R; Goetller A; Zuge C; Balzoa P; Cooley G
Med Dosim; 2009; 34(3):207-13. PubMed ID: 19647630
[TBL] [Abstract] [Full Text] [Related]
18. Multi-institutional experience using the MammoSite radiation therapy system in the treatment of early-stage breast cancer: 2-year results.
Cuttino LW; Keisch M; Jenrette JM; Dragun AE; Prestidge BR; Quiet CA; Vicini FA; Rescigno J; Wazer DE; Kaufman SA; Ramakrishnan VR; Patel R; Arthur DW
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):107-14. PubMed ID: 18037585
[TBL] [Abstract] [Full Text] [Related]
19. Five-year results: the initial clinical trial of MammoSite balloon brachytherapy for partial breast irradiation in early-stage breast cancer.
Benitez PR; Keisch ME; Vicini F; Stolier A; Scroggins T; Walker A; White J; Hedberg P; Hebert M; Arthur D; Zannis V; Quiet C; Streeter O; Silverstein M
Am J Surg; 2007 Oct; 194(4):456-62. PubMed ID: 17826055
[TBL] [Abstract] [Full Text] [Related]
20. Long-term follow-up of the SBG 9401 study comparing tailored FEC-based therapy versus marrow-supported high-dose therapy.
Wilking N; Lidbrink E; Wiklund T; Erikstein B; Lindman H; Malmström P; Kellokumpu-Lehtinen P; Bengtsson NO; Söderlund G; Anker G; Wist E; Ottosson S; Salminen E; Ljungman P; Holte H; Nilsson J; Blomqvist C; Bergh J
Ann Oncol; 2007 Apr; 18(4):694-700. PubMed ID: 17301072
[TBL] [Abstract] [Full Text] [Related]
[Next]
